<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>7(3)</volume><submitter>Patel P</submitter><pubmed_abstract>Hepatocellular carcinoma is on the rise and occurs in the setting of chronic liver disease and cirrhosis. Though treatment modalities are available, mortality from this cancer remains high. Medical therapy with the utilization of biologic compounds such as the Food and Drug Administration approved sorafenib might be the only option that can increase survival. Immunotherapy, with modern pharmacologic developments, is a new frontier in cancer therapy and therefore the immunobiology of hepatocarcinogenesis is under investigation. This review will discuss current concepts of immunobiology in hepatocarcinogenesis along with current treatment modalities employing immunotherapy. The tumor microenvironment along with a variety of immune cells coexists and interplays to lead to tumorigenesis. Tumor</pubmed_abstract><journal>World journal of gastrointestinal pathophysiology</journal><pagination>242-55</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC4981764</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Immunobiology of hepatocarcinogenesis: Ways to go or almost there?</pubmed_title><pmcid>PMC4981764</pmcid><pubmed_authors>Patel P</pubmed_authors><pubmed_authors>Pyrsopoulos N</pubmed_authors><pubmed_authors>Schutzer SE</pubmed_authors></additional><is_claimable>false</is_claimable><name>Immunobiology of hepatocarcinogenesis: Ways to go or almost there?</name><description>Hepatocellular carcinoma is on the rise and occurs in the setting of chronic liver disease and cirrhosis. Though treatment modalities are available, mortality from this cancer remains high. Medical therapy with the utilization of biologic compounds such as the Food and Drug Administration approved sorafenib might be the only option that can increase survival. Immunotherapy, with modern pharmacologic developments, is a new frontier in cancer therapy and therefore the immunobiology of hepatocarcinogenesis is under investigation. This review will discuss current concepts of immunobiology in hepatocarcinogenesis along with current treatment modalities employing immunotherapy. The tumor microenvironment along with a variety of immune cells coexists and interplays to lead to tumorigenesis. Tumor</description><dates><release>2016-01-01T00:00:00Z</release><publication>2016 Aug</publication><modification>2025-04-26T21:59:25.906Z</modification><creation>2019-03-27T02:20:28Z</creation></dates><accession>S-EPMC4981764</accession><cross_references><pubmed>27574562</pubmed><doi>10.4291/wjgp.v7.i3.242</doi></cross_references></HashMap>